Enovix Corp is trading 5.4% down at $6.92 following renewed execution concerns linked to leadership changes in management and manufacturing.
- Sentiment turned cautious after hedge fund commentary highlighted the departure of a key manufacturing process lead ahead of critical product ramps.
- The stock is also facing pressure from a broader sell-off in the technology sector as investors navigate a softer risk environment.